Sex Steroid Hormone Polymorphisms, High-Density Lipoprotein Cholesterol, and Apolipoprotein A-1 from the Study of Women's Health Across the Nation (SWAN)

American Journal of Medicine

Volumn 119, Issue 9 SUPPL. 1, 2006, Pages

  Sowers, MaryFran R ^a   Symons, James P ^a   Jannausch, Mary L ^a   Chu, Jian ^a   Kardia, Sharon R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Apolipoprotein A 1; Estrogen receptors; Genetics; High density lipoprotein cholesterol; Single nucleotide polymorphisms

Indexed keywords

APOLIPOPROTEIN A1; DNA; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD; CAUCASIAN; CHINESE; CLIMACTERIUM; CONTROLLED STUDY; ETHNOLOGY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEART PROTECTION; HUMAN; LIPID ANALYSIS; LYMPHOCYTE TRANSFORMATION; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; RACE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; APOLIPOPROTEIN A-I; CHOLESTEROL, HDL; CONTINENTAL POPULATION GROUPS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HEALTH SURVEYS; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33747873901     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.07.008     Document Type: Article

References (43)

1. Brinton E.A. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 16 (1996) 431-440
2. de Kleijn M.J., van der Schouw Y.T., and van der Graaf Y. Reproductive history and cardiovascular disease risk in postmenopausal women: a review of the literature. Maturitas 33 (1999) 7-36
3. Solomon C.G., Hu F.B., Dunaif A., et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 87 (2002) 2013-2017
4. Bairey Merz C.N., Johnson B.D., Sharaf B.L., et al., WISE Study Group. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 41 (2003) 413-419
5. Rossouw J.E., Anderson G.L., Prentice R.L., et al., Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
6. Hulley S., Grady D., Bush T., et al., Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-613
7. Darblade B., Pendaries C., Krust A., et al. Estradiol alters nitric oxide production in the mouse aorta through the α-, but not β-, estrogen receptor. Circ Res 90 (2002) 413-419
8. Lubahn D.B., Moyer J.S., Golding T.S., Couse J.F., Korach K.S., and Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A 90 (1993) 11162-11166
9. Couse J.F., Curtis S.W., Washburn T.F., et al. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 9 (1995) 1441-1454
10. Pendaries C., Darblade B., Rochaix P., et al. The AF-1 activation-function of ERα may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci U S A 99 (2002) 2205-2210
11. -/- mice. J Clin Invest 107 (2001) 333-340
12. Almeida S., Franken N., Zandoná M.R., Osória-Wender M.C., and Hutz M.H. Estrogen receptor 2 and progesterone receptor gene polymorphisms and lipid levels in women with different hormonal status. Pharmacogenomics J 5 (2005) 30-34
13. Mahaney M.C., Blangero J., Comuzzie A.G., VandeBerg J.L., Stern M.P., and MacCluer J.W. Plasma HDL cholesterol, triglycerides, and adiposity: a quantitative genetic test of the conjoint trait hypothesis in the San Antonio Family Heart Study. Circulation 92 (1995) 3240-3248
14. Austin M.A., Talmud P.J., Luong L.A., et al. Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am J Hum Genet 62 (1998) 406-419
15. Xu J.F., Prenger V.L., Coresh J., and Beaty T.H. Two-locus and bivariate segregation analysis of HDL-C and apo AI. Genet Epidemiol 10 (1993) 605-610
16. Herrington D.M., Howard T.D., Hawkins G.A., et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 346 (2002) 967-974
17. Manninen V., Tenkanen L., and Koskinen P. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 85 (1992) 37-45
18. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 62 (1977) 707-714
19. Sowers M.F., Crawford S., Sternfeld B., et al. Design, survey sampling and recruitment methods of SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo R.A., Kelsey J., and Marcus R. (Eds). Menopause: Biology and Pathobiology (2000), Academic Press, San Diego, CA 175-188
20. Kardia S.R., Chu J., and Sowers M.F. Characterizing variation in sex steroid hormone pathway genes in women of 4 races/ethnicities: the Study of Women's Health Across the Nation (SWAN). Am J Med 119 suppl 9A (2006) S3-S15
21. Single Nucleotide Polymorphism database: dbSNP search page. National Center for Biotechnology Information Web site. Available at: http://www.ncbi.nlm.nih.gov/SNP/. Accessed September 25, 2005.
22. Steiner P., Freidel J., Bremner W., and Stein E. Standardization of micromethods for plasma cholesterol, triglyceride and HDL-cholesterol with the lipid clinics' methodology [abstract]. J Clin Chem 19 (1981) 850
23. Warnick G.R., and Albers J.J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high-density lipoprotein cholesterol. J Lipid Res 19 (1978) 65-76
24. Myers G.L., Cooper G.R., Winn C.L., and Smith S.J. The Centers for Disease Control-National Heart, Lung, and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements. Clin Lab Med 9 (1989) 105-135
25. Ferris B. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 118 (1978) 1-120
26. Baecke J.A., Burema J., and Fritjers J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36 (1982) 936-942
27. Sternfeld B., Ainsworth B.E., and Quesenberry C.P. Physical activity patterns in a diverse population of women. Prev Med 28 (1999) 313-323
28. Matthews K.A., Sowers M.F., Derby C.A., et al. Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). Am Heart J 149 (2005) 1066-1073
29. Beer D.G., Kardia S.L.R., Huang C.-C., et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8 (2002) 816-824
30. R Development Core Team. R: A Language and Environment for Statistical Computing (2005), R Foundation for Statistical Computing, Vienna, Austria
31. Dean B.B., Borenstein J.E., Henning J.M., Knight K., and Bairey Merz C.N. Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?. Am Heart J 147 (2004) 966-976
32. Losordo D.W., Kearney M., Kim E.A., Jekanowski J., and Isner J.M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89 (1994) 1501-1510
33. Karas R.H., Patterson B.L., and Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89 (1994) 1943-1950
34. Venkov C.D., Rankin A.B., and Vaughan D.E. Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function. Circulation 94 (1996) 727-733
35. Grohé C., Kahlert S., Löbbert K., et al. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416 (1997) 107-112
36. Sudhir K., Chou T.M., Chatterjee K., et al. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 96 (1997) 3774-3777
37. Smith E.P., Boyd J., Frank G.R., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331 (1994) 1056-1061
38. Hodges Y.K., Richer J.K., Horwitz K.B., and Horwitz L.D. Variant estrogen and progesterone receptor messages in human vascular smooth muscle. Circulation 99 (1999) 2688-2693
39. Schuit S.C.E., Oei H.H.S., Witteman J.C.M., et al. Estrogen receptor α gene polymorphisms and risk of myocardial infarction. JAMA 291 (2004) 2969-2977
40. Herrington D.M., Howard T.D., Brosnihan K.B., et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105 (2002) 1879-1882
41. Koivu T.A., Fan Y.M., Mattila K.M., et al. The effect of hormone replacement therapy on atherosclerotic severity in relation to ESR1 genotype in postmenopausal women. Maturitas 44 (2003) 29-38
42. Matsubara Y., Murata M., Kawano K., et al. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 17 (1997) 3006-3012
43. Ruaño G., Seip R.L., Windemuth A., et al. Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training. Atherosclerosis 185 (2006) 65-69